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Crystal structures of Bacillus caldovelox arginase in complex
with substrate and inhibitors reveal new insights into activation,
inhibition and catalysis in the arginase superfamily
Maria C Bewley1†*, Philip D Jeffrey1‡, Mark L Patchett1, Zoltan F Kanyo2§
and Edward N Baker1#*
Background: Arginase is a manganese-dependent enzyme that catalyzes the
hydrolysis of L-arginine to L-ornithine and urea. In ureotelic animals arginase is
the final enzyme of the urea cycle, but in many species it has a wider role
controlling the use of arginine for other metabolic purposes, including the
production of creatine, polyamines, proline and nitric oxide. Arginase activity is
regulated by various small molecules, including the product L-ornithine. The aim
of these structural studies was to test aspects of the catalytic mechanism and
to investigate the structural basis of arginase inhibition.
Results: We report here the crystal structures of arginase from Bacillus
caldovelox at pH 5.6 and pH 8.5, and of binary complexes of the enzyme with
L-arginine, L-ornithine and L-lysine at pH 8.5. The arginase monomer comprises
a single compact α/β domain that further associates into a hexameric
quaternary structure. The binary complexes reveal a common mode of ligand
binding, which places the substrate adjacent to the dimanganese centre. We
also observe a conformational change that impacts on the active site and is
coupled with the occupancy of an external site by guanidine or arginine.
Conclusions: The structures reported here clarify aspects of the active site and
indicate key features of the catalytic mechanism, including substrate
coordination to one of the manganese ions and an orientational role for a
neighboring histidine residue. Stereospecificity for L-amino acids is found to
depend on their precise recognition at the active-site rim. Identification of a
second arginine-binding site, remote from the active site, and associated
conformational changes lead us to propose a regulatory role for this site in
substrate hydrolysis.
Introduction
Arginase (L-arginine amidinohydrolase, E.C. 3.5.3.1) is a
metal ion dependent enzyme that catalyzes the hydroly-
sis of L-arginine to L-ornithine and urea [1]. The enzyme
is widely distributed throughout the evolutionary spec-
trum in organisms as diverse as bacteria, yeast, plants and
animals (for a review, see [2]), although some prokaryotic
species instead contain a related enzyme that may fill a
similar role. The general biological importance of arginase
lies in its role in controlling cellular levels of arginine and
ornithine, which are required for various critical metabolic
processes, including protein synthesis and the production
of creatine, polyamines, proline and nitric oxide (NO). In
higher animals arginase exists in at least two different
isoforms, which differ in tissue distribution and phys-
iological function [3]. Type I arginase, which is highly
expressed in the livers of ureotelic animals, has a key role
in the urea cycle, converting highly toxic ammonium ions
into neutral urea that is removed from the body. Arginase
catalyzes the final step in this cycle, after which one
product (urea) is excreted and the other (ornithine) is
returned to the cycle for further rounds of urea produc-
tion. Type II arginase, which is found in a wide variety of
different tissues, may have a key role in the regulation of
extra-urea-cycle arginine metabolism by regulating levels
of arginine in the cell. 
In eukaryotes, the central role of arginase in nitrogen
metabolism requires its activity to be regulated. Thus it is
inhibited by various metabolites, including its product, L-
ornithine, various other L-amino acids and by N-hydroxy-
L-arginine, an intermediate in the production of NO
from arginine [4]. The latter observation emphasizes its
likely importance for NO-mediated signaling pathways and
inflammatory responses. Point mutations in the arginase
gene have been shown to result in arginase deficiency,
resulting in hyperargininemia, with consequent mental dis-
orders, retarded development, seizures and early death [5,6].
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Amino acid sequence alignments and comparisons of argi-
nase with other proteins indicate that it is part of a larger
superfamily that includes two other proteins, agmatine ure-
ohydrolase and formiminoglutamate hydrolase [7,8]. Argi-
nases are characterized by a conserved set of three signature
sequences, GGDHS, SXDXDXDP and DAHXD, where
X is any amino acid. The majority of sequence differences
in eukaryotic arginases occur in extensions at the N and
C termini relative to the bacterial arginases, such as those of
Bacillus caldovelox and Bacillus  subtilis that lack the C-termi-
nal extension. Arginases are homo-oligomers, with a typical
subunit mass of 32–36 kDa [2]. Eukaryotic arginases are
predominantly trimeric, whereas the bacterial enzymes are
generally thought to be hexameric [2]; there is no evidence
of cooperativity, however, and it has been shown for human
arginase that the monomer is active [9,10], suggesting that
each monomer has a full complement of active-site residues.
The structure of rat arginase [11] revealed its dimanganese
active site and led to a proposed mechanism of hydrolysis in
which a metal-bridging water molecule or hydroxide ion ini-
tiated the nucleophilic attack of the substrate guanidino
carbon atom. This mechanism was based on modeling the
L-arginine substrate into the active site, in the absence of
direct structural evidence for the mode of substrate binding.
A second proposed mechanism, based on electron paramag-
netic resonance (EPR) studies postulates direct coordina-
tion of the substrate to manganese and disruption of the
aquo bridge as key features [12].
This study was undertaken with several goals in mind.
The rat arginase structure revealed the nature of its
trimeric association, which is largely facilitated by interac-
tions involving a 14-residue C-terminal extension termed
an ‘oligomerization motif’ [11]. Sequence alignments indi-
cate that this motif is absent in bacterial arginases, however,
raising questions about their oligomeric organization. In
order to resolve this issue, we have determined the struc-
ture of the bacterial arginase from B. caldovelox at pH 8.5
and pH5.6 to high resolution and two other structures at a
more modest resolution. To test the two proposed catalytic
mechanisms, and the basis of ligand recognition and
binding, we have also solved the structures of binary com-
plexes of arginase with either bound substrate or inhibitor.
Comparisons of the structures of the holoenzyme and the
L-arginine–arginase complex at pH 8.5 with that of the
holoenzyme at pH 5.6 show an unexpected conformational
change that suggests a possible mechanism of regulating
arginase activity. These structures clarify the structural
basis of arginase stereospecificity and identify key factors in
the activity and  inhibition of the enzyme.
Results and discussion
Structure determination and model quality
B. caldovelox arginase was crystallized in five different
crystal forms, under both low- and high-salt conditions and
at pH values between 5.6 and 8.5. Only two of the crystal
forms, form I (at pH 5.6) and form II (at pH 8.5), dif-
fracted to reasonably high resolution and are described
here. The crystal structures of both forms were solved by
molecular replacement using the coordinates of rat liver
arginase as a search model [11]. Binary complexes with 
L-arginine, L-ornithine and L-lysine were all crystallized at
pH 8.5 and were isomorphous with the form II native crys-
tals. In all cases, the high level of noncrystallographic sym-
metry (six molecules in the asymmetric unit) markedly
enhanced the quality of the electron-density maps. Full
details of the structure determination and refinement are
given in the Materials and methods section and the final
refinement statistics are listed in Table 1.
The structures are well defined, with only two regions of
uncertainty: in the pH 8.5 structure the N-terminal residue
is missing and in both structures there is poor density for an
exposed surface loop (residues 55–63). This exposed loop is
included in both models, but has high B factors (70–100 Å2)
and different conformations, possibly as a result of crystal-
packing differences. Both models have good stereochem-
istry and all residues fall in the allowed region of the
Ramachandran plot, with 90% of residues falling within
the most favorable region, as defined by PROCHECK [13].
Two cis peptides have been found between Gly96–Gly97
and Ser161–Pro162, respectively.
The arginase monomer
The structure of the arginase monomer is shown in
Figure 1a. The fold is the same as that of rat arginase [11];
both are comprised of an eight-stranded parallel β sheet
with helices packed on either side to form a single α/β
domain of approximate dimensions 40 Å × 50 Å × 50 Å.
The strands are arranged in the order 2-1-3-8-7-4-5-6
when numbered according to their positions in the poly-
peptide chain. Each strand is linked to the next by an
α helix such that three helices (αB, αC and αD) are
packed against one face of the β sheet and four helices
(αA, αG, αH and αI) are packed against the other. Helices
αE and αF are on the periphery, alongside the outer
strand β6 and are used in oligomerization. The fold is also
characterized by short loops joining the secondary struc-
ture elements at the N-terminal ends of the β strands and
long loops joining the elements at their C-terminal ends;
the long loops combine to create the active-site cavity.
In comparison with the rat enzyme, the polypeptide chain
of B. caldovelox arginase is 24 amino acids shorter, making
it one of the shorter arginase sequences. The major differ-
ence is a 14-residue deletion from the C terminus, whereas
elsewhere in the molecule, insertions and deletions are
minimal. There is a four-residue deletion at the N termi-
nus, a three-residue deletion at the start of helix αD, a
single-residue deletion from the αG–β7 loop and a four-
residue deletion from the β8–αI loop. The sole insertion
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in the B. caldovelox structure relative to rat arginase com-
prises a two-residue insertion (60–61) in the β2–αB loop.
The similarity in their sequence, and thus fold, is reflected
in the superposition of the two enzymes: 248 structurally
equivalent Cα atoms (83% of the B. caldovelox sequence)
of the two arginases superimpose with a root mean square
(rms) difference of 0.75 Å.
The pH 5.6 and pH 8.5 structures of B. caldovelox arginase
are extremely similar; superposition shows that 281 Cα
atoms (residues 2–13, 20–53, 65–299) can be matched with
an rms difference of only 0.40 Å. Apart from the poorly
ordered loop, residues 55–63 (mentioned above), there is
only one region where significant deviations occur. This
involves the β1–αA loop (residues 12–20) at the rim of the
active-site cavity. The electron density for this loop is well
defined in both structures, and its rearrangement seems to
have important consequences for the active site and for
catalysis. This will be discussed in the context of the
binary complexes.
Oligomerization
Various oligomeric states have been reported for arginases,
although, in general, the eukaryotic arginases tend to be
trimeric whereas the bacterial ones tend to be hexameric
[2]. Suggestions of a pH dependence for oligomerization
[14] led us to determine the structure of arginase in a
series of different crystal forms between pH 5.6 and 8.5 —
the two crystal forms reported here and three others that
diffract to lower resolution (MCB, PDJ, MLP and ENB,
unpublished data). All crystal forms contain either three or
six molecules in the asymmetric unit; a similar trimer is
found in every case, with hexamers then being formed by
the association of pairs of trimers via crystallographic or
noncrystallographic twofold axes.
Trimer formation by B. caldovelox arginase results in a
central tunnel at the threefold axis and involves the same
principal contact regions in all crystal forms (Figure 1b).
These regions fall into two groups. At the inner end of the
interface, by the central tunnel, residues on the hydro-
philic face of helix αH of one monomer interact with the
same region of a neighboring molecule across a twofold
axis and also interact with Met195 and Asp199 from helix
αF. These residues are conserved in both trimeric and
hexameric arginases. Further out from the centre, Lys182
and Arg186, residues of conserved character, interact with
the three nonconserved C-terminal residues, 297–299. Spe-
cific interactions between the monomers are dominated by
salt bridges, His196–Glu256, Asp199–Arg249, Arg200–
Glu260, Glu250–Arg249 and Arg186–299 COO–; many of
these interactions are multivalent, giving a total of 12
hydrogen bonds at each interface. The surface area buried
per monomer upon trimerization (1280 Å2) is low com-
pared to other oligomeric proteins [15]. This suggests that
the oligomers assemble from preformed monomers, requir-
ing little change in conformation to do so, as opposed to
proteins that bury a large surface area upon oligomer-
ization and may be unstable as a monomer. Support for
this theory is given by human arginase, which is active as
a monomer [9,10].
The additional 14 residues at the C terminus of the rat
enzyme provide a striking contrast with B. caldovelox arginase.
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Table 1
Summary of data collection and refinement statistics.
Crystal form I II L-Arginine L-Ornithine L-Lysine
Data collection
pH 5.6 8.5 8.5 8.5 8.5
Unit-cell dimensions
a, b, c (Å) 83.6, 145.6, 155.4 106.22, 275.58, 138.07 106.8, 277.7, 140.0 106.6, 277.3, 139.7 106.4, 277.0, 138.8
Space group P212121 C2221 C2221 C2221 C2221
Resolution range (Å) 40.0–2.4 40.0–2.15 50.0–2.4 50.0–2.7 50.0–2.5
No. observations 286,814 436,708 201,956 161,259 424,670
Unique reflections 68,531 93,307 73,511 53,853 68,127
Completeness (%)* 90.9 (67.1) 87.9 (63.2) 89.7 (52.4) 93.5 (82.4) 94.9 (72.7)
Rmerge*† 7.1 (34.4) 6.7 (27.1) 5.2 (16.9) 9.7 (21.9) 6.7 (18.8)
I/σI* 15.8 (2.8) 15.4 (3.1) 14.1 (3.8) 10.1 (3.0) 18.0 (4.8)
Refinement
Resolution range (Å) 6.0–2.4 6.0–2.15 8.0–2.4 8.0–2.7 8.0–2.5
No. reflections 60,117 87,695 68,674 48,983 63,576
R factor 20.5 19.5 19.3 20.3 21.2
R free‡ 26.5 23.8 24.3 27.4 26.1
Water/hexamer 486 668 637 174 378
Rms bond length (Å) 0.012 0.010 0.010 0.010 0.011
Rms bond angles (°) 1.50 1.42 1.42 1.42 1.47
*Figures in parentheses refer to the data in the outermost shell. †Rmerge = no sigma cut-off. ‡R free was calculated for 5% of the data.
These extra residues, which follow an S-shaped course,
have been termed an oligomerization motif [11] and provide
half of the buried surface at the monomer interface in the
rat enzyme. One consequence of the absence of the oligo-
merization motif is that the solvent-excluded surface at each
monomer–monomer interface is markedly less in the B. cal-
dovelox enzyme (1280 Å2) than in the rat enzyme (1820 Å2)
when calculated using the method of Lee and Richards with
a 1.4 Å probe [16]. The absence of the motif from the B. cal-
dovelox arginase interface produces only small effects in the
packing of the trimer, however. Indeed, when a monomer of
rat arginase is superimposed on a B. caldovelox monomer,
the rotations required to align the second and third pairs are
less than 4º. Thus we conclude that the oligomerization
motif is not essential for trimer formation.
Cross-linking experiments and electron microscopy (EM)
studies (MCB and J Wall, unpublished results) confirm
that above pH 7.0 the protein is hexameric. Inspection of
the crystal structures shows that there are two possible
modes of hexamer formation, which bury 685 Å2 and 260 Å2
of surface area per monomer, respectively (Figures 2a and b).
It would appear that the additional surface area buried
upon hexamerization compensates, to some degree, for
the loss of interactions that results from the absence of the
oligomerization motif. Hexamer 1 is formed when one
trimer is rotated 20° with respect to the other about a
common threefold axis. In this hexamer contacts between
the trimers involve two main regions: residues 274–280 of
one monomer contact the same region of a neighboring
monomer across a twofold axis, and residues 18–29 make
similar twofold-related contacts. Of the 19 residues involved
in this interface, 16 are conserved in the B. subtilis argi-
nase, which is also hexameric. In hexamer 2, interactions
involve primarily Arg205 and Glu208 with their symmetry
equivalents. Hexamer 1 is common to both crystal forms
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Figure 1
The monomer and trimer of B. caldovelox
arginase. (a) The monomer is shown in two
mutually perpendicular views. The manganese
ions are colored in magenta; α helices and
β strands are in red and green, respectively,
and loops are in cyan. (b) The trimer is
comprised of three identical subunits that
associate to form a flat disc-like structure.
(The figure was prepared with MOLSCRIPT
[36] and Raster3D [37,38].)
reported here and to the three lower resolution structures
(MCB, PDJ, MLP and ENB, unpublished results) and
this is assumed to be the one preferentially formed in
solution. Interestingly, however, the additional mode of
association (hexamer 2) seen in crystal form I results in
long oligomeric arrays that form tubes of molecules which
extend through the crystal lattice, using both interfaces.
This might suggest that, under these conditions, oligo-
merization could occur at either trimer face. Indeed, early
reports in the literature suggested that, in some species,
arginase could form hetero-oligomers with ornithine car-
bamoyl transferase [17,18]. Although ornithine carbamoyl
transferase activity has not been demonstrated in B. cal-
dovelox, it is possible that the tubes of oligomers seen
here might model these hetero-oligomers in related
hexameric species. 
The active site
The active-site cavity is created principally by two long
loops (residues 124–141 and 228–246), which enclose the
dimanganese active site. At the bottom of this cavity are
the catalytic manganese ions, MnA and MnB (Figure 3).
These ions are 3.3 Å apart and the metal-binding sites are
fully occupied at pH 8.5, as estimated by crystallographic
refinement. The two manganese ions are asymmetrically
arranged with respect to the active-site cavity; MnA
(bound to His99) is deeper in the cavity and MnB (bound
to His124) is closer to the surface and more solvent-
exposed. The manganese ions are linked by a set of bridg-
ing ligands of three types: the carboxylate group of Asp122
binds as a bidentate bridging ligand, with Oδ1 bound to
MnA and Oδ2 bound to MnB; the carboxylate oxygen Oδ1
of Asp226 acts as a monodentate bridging ligand, bound to
both MnA and MnB; and a water molecule bridges both
metal ions. When combined with the other metal ligands,
(His99 Nδ1, Asp126 Oδ1 and a second water molecule,
OW7, bound to MnA; His124 Nδ1 and Asp228 Oδ1 and
Oδ2 bound to MnB) the bridging ligands give rise to two
six-coordinate Mn(II) ions, each with an approximately
octahedral geometry (Figure 3).
In the structure at pH 5.6, the metal–ligand bond lengths
are approximately the same although the His124 Nδ1–
MnB bond is lengthened, indicating that MnB might be
preferentially released. This conclusion is reinforced by
the observation that MnB was preferentially removed by
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Figure 2
B. caldovelox arginase hexamer formation.
The different types of hexamer are shown in
two perpendicular orientations. (a) Hexamer 1.
This hexamer is observed in all crystal forms
and is likely to be the biological unit. One half
of the hexamer is colored as in Figure 1 and
the other half is colored in different shades of
pink to highlight the secondary structure
elements. (b) Hexamer 2 is observed in the
pH 5.6 crystal form. This hexamer may model
potential interactions of arginase with other
proteins. One half of the hexamer is colored
as in Figure 1 and the other half of the
hexamer is colored in different shades of
purple to highlight the secondary structure
elements. (The figure was prepared with
MOLSCRIPT [36] and Raster 3D [37,38].)
ethylenediamine tetra-acetate (EDTA) during experiments
to prepare a substrate complex (see later) and is in marked
contrast to rat arginase in which MnA was lost preferen-
tially when the crystal was soaked in EDTA [19].
A feature of the active site is a cis peptide bond, between
Gly96 and Gly97, which forms part of the conserved
GGDHS motif. Such cis peptide bonds involving residues
other than proline are rare [20], but several have been
observed where they help shape the active sites of
enzymes [21,22]. In arginase, the amide nitrogen of the cis
peptide bond is hydrogen bonded to the carbonyl oxygen
of residue 20 and the carbonyl oxygen of the cis peptide
bond is hydrogen bonded to an internal water molecule.
This structure may be important in positioning His99
to coordinate one of the manganese atoms. In the rat
arginase structures [11,19], this peptide was initially
modeled in the trans conformation, but the electron
density has been re-evaluated in the light of these results,
and the peptide is now in the cis conformation [23].
Superficially the active sites of the rat and bacterial
arginases are similar. In the published structure of rat
arginase, the geometry of MnA was reported to be square
pyramidal [11], but extended X-ray absorption fine struc-
ture (EXAFS) experiments indicated that both manganese
ions were six-coordinated [24]. In B. caldovelox arginase
both manganese ions have distorted octahedral geometry,
as a second water molecule provides the extra ligand for
MnA. On the basis of this result, further analysis of the rat
arginase structure has shown weak density for a water mol-
ecule in an analogous position [23], suggesting that the
manganese ions in both species have octahedral geometry.
A feature of the rat arginase structure was that each of the
bridging ligands was bound symmetrically between the
two manganese ions. For B. caldovelox arginase, we ini-
tially restrained the bridging metal–ligand bonds to be
symmetric, but in the course of refinement it became
evident that they are not. This may correlate with changed
metal selectivity: in B. caldovelox arginase, the manganese
ions can be substituted by nickel ions and remain active
[14], whereas in rat this substitution is inhibitory [11].
Further, the Mn–O bond lengths for the bridging solvent
molecule consistently refined to values (2.0 and 2.2 Å,
respectively) that are shorter than in rat arginase (both
2.4 Å). Although at this resolution we cannot confidently
differentiate between a hydroxide or aquo species, a
hydroxide ion is expected at pH 8.5, and our bond lengths
are consistent with this.
The geometry of the active site appears to be shaped
by second-shell residues, which position the manganese
ligands [19]. Most of the second-shell residues are con-
served across species, but variations may lead to differ-
ences in metal binding. In comparing the B. caldovelox and
rat enzymes, we noted one key substitution: Ser176 in
B. caldovelox is equivalent to Asp182 in rat. This substitu-
tion changes the hydrogen-bonding pattern of the man-
ganese ligand His124, which forms a hydrogen bond with
Asp182 in rat and with a water molecule in the B. cal-
dovelox structure. This may explain why MnB, attached to
His124, is more easily removed in B. caldovelox arginase.
The change also impacts on the water structure close to
the manganese site and may explain the differences in
metal ion substitution and water coordination, as well as
metal release.
The disruption of second-shell interactions can have dis-
astrous metabolic consequences. One cause of the meta-
bolic disease argininemia is a point mutation of Gly235→
Arg in the human arginase gene, which renders the
enzyme inactive [6]. Gly235 is conserved between mam-
malian and bacterial species and our structures show it to
be located in a hydrophobic pocket close to the active site.
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Figure 3
The dimanganese active site of B. caldovelox
arginase. Each Mn(II) ion is octahedrally
coordinated by six ligand atoms. The
manganese ions are shown as large magenta
spheres, and water molecules as smaller
green spheres; oxygen atoms are colored red,
nitrogen atoms blue and carbon atoms black.
The probable hydrogen bond between the
bridging water/hydroxide and the non-
coordinated carboxylate oxygen atom of
Asp126 is shown with a broken line. (The
figure was prepared with MOLSCRIPT [36]
and Raster 3D [37,38].)
Other species contain alanine, cysteine or phenylalanine
at this position; these residues can potentially be accom-
modated within the hydrophobic environment. By inspec-
tion of the B. caldovelox or rat structures it can be seen that
an arginine residue in this position would either place a
charged residue in a hydrophobic pocket or interfere with
manganese binding at the active site. In either case, it
seems likely that the arginine residue interferes with the
local environment of the active site. 
Substrate and inhibitor complexes
The crystal structures of arginase in complex with L-argi-
nine, L-ornithine and L-lysine have been solved to a reso-
lution of 2.4 Å, 2.7 Å and 2.5 Å, respectively. In each case
the crystals were obtained at pH 8.5, under the same con-
ditions as used for crystal form II, with the ligands bound
either by cocrystallization (L-ornithine and L-lysine com-
plexes) or by soaking into inactivated holoenzyme crystals
(L-arginine complex). The crystals were isomorphous, and
the structures were solved using the native pH 8.5 struc-
ture as a starting model. Full details are given in the Mate-
rials and methods section. No gross conformational changes
occur upon substrate binding or inhibition.
Stereospecific ligand recognition
The substrate and inhibitors bind in the active site with the
end of their sidechain adjacent to the manganese ions and
their backbone bound at the periphery of the active site,
under part of the rim formed by residues 133–139 and
176–181. The backbone binds in a similar way in all sub-
strate and inhibitor complexes, as shown in Figure 4a, and
causes no local conformational changes in the protein, indi-
cating that it is likely to be the mode of binding in vivo.
The substrate and inhibitors are bound to the protein by a
number of specific interactions that recognize each polar
atom of their backbone (Figure 4a). In each case, the
α-amino group is close to two carboxylate groups, of Asp178
and Glu181, and is tetrahedrally surrounded by three poten-
tial hydrogen-bond acceptors at distances of < 3.0 Å (i.e.
Asp178 Oδ2 and two water molecules). The latter are
bound to Glu181 Oε1, Asp178 Oδ1, Ser176 Oγ, Ser176 O,
Asp126 N and Gly140 O, all within the active-site cavity.
For the α-carboxyl group, each carboxylate oxygen atom
forms two hydrogen bonds of < 3.0 Å. One oxygen is hydro-
gen bonded to Asn128 Nδ2 and a water molecule, which
in turn is hydrogen bonded to Ser135 Oγ and Asn137 O.
The other oxygen atom is hydrogen bonded to Ser135 Oγ
and a water molecule, which in turn interacts with the
sidechain atoms of His139 and Asn137. In this way, the
backbone atoms of the substrate and inhibitors achieve
their full hydrogen-bond complement. The protein side-
chains involved are conserved in virtually all arginases and
although a number of water molecules are involved most
of these are conserved too, in both the presence and
absence of ligand.
The resulting hydrogen-bonding pattern allows the enzyme
to recognize the precise geometry of the backbone in a
stereospecific manner, discriminating between D- and L-
isomers. In fact, a racemic mixture of D/L-ornithine was used
in the crystallization of the ornithine–arginase complex, but
density for the L-isomer alone was observed. In addition, it
has been shown that arginase does not hydrolyze D-arginine
and that D-arginine does not inhibit L-arginine hydrolysis
[14]. Thus, we propose that there is specific recognition of
the L-isomer of the substrate or inhibitor at this site.
The mode of binding seen here (Figure 4a) is different
from that observed in a recent structure of rat arginase in
complex with ornithine and borate [25]. In the latter,
ornithine was found hydrogen bonded to the sidechain of
Arg21, in two of the three monomers, after soaking native
crystals in ornithine and borate. We suggest, however, that
this is a secondary site, occupied as a result of using two
inhibitors together, and that the primary site of arginase
inhibition by amino acid inhibitors is that seen in our
binary complexes and shown in Figure 4.
Substrate binding
For preparation of the substrate-bound complex, arginase
crystals were grown in the presence of EDTA, to remove
manganese ions, and then L-arginine was diffused into
these crystals (see Materials and methods section). The
arginine molecule and one manganese ion (MnA) were
clearly visible in the electron density. There was density
close to where MnB had been in the native structure, but
this density was smaller and displaced from the site of
MnB in the native structure. Distances from the centre of
the density to its nearest neighbors were more consistent
with it being a water molecule, which is a ligand to MnA
and hydrogen bonds to the ligands of MnB. The assign-
ment of this density to a water molecule held during crys-
tallographic refinement. In addition, crystals subjected to
the same conditions as the exposed crystal were dissolved
and analyzed by atomic absorption spectroscopy. The
resultant solution was shown to contain an average of one
manganese ion per monomer. 
The sidechain atoms of the L-arginine substrate lie in an
extended conformation with the guanidine group packing
against the sidechain of His139, in such a way that the
guanidine and imidazole ring planes are parallel and about
3.3 Å apart. In this position, the full hydrogen-bonding
potential of the guanidine group is satisfied: Nε forms a
hydrogen bond (2.8 Å) to a carboxylate oxygen of the
manganese ligand, Asp126; Nη1 is hydrogen bonded to
Thr240 Oγ1 (3.0 Å) and an internal water molecule (3.0 Å);
and Nη2, hydrogen bonds to His139 O (2.9 Å) and the car-
boxylate oxygen Oε2 of Glu271 (3.0 Å) (see Figure 4b).
Most significantly, Nη2 has replaced the terminal water
ligand of MnA and appears to be coordinated as a sixth
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ligand to MnA at a distance of 2.5 Å. Coordination of the
guanidine group to manganese implies that it should be in
its unprotonated state, with one terminal nitrogen in the
amino form and the other in the imino form. The nature
and geometry of their interactions supports this interpreta-
tion. The hydrogen-bond partners for Nη2 are both accep-
tors, implying that it carries two protons, and the bond
angles at this nitrogen, Cζ–Nη2–MnA, Cζ–Nη2…O(139)
and Cζ–Nη2–Oε2 are 110°, 105° and 99°, respectively,
consistent with sp3 hybridization. The lone pair of elec-
trons would point directly at MnA and the two hydrogen
bonds would be linear. The hydrogen-bond partners for
Nη1, on the other hand, can act as donors or acceptors and
are approximately coplanar with the guanidine group. The
resulting geometry (Cζ-Nη1…Oγ(240) and Cζ-Nη1…OW
of 142° and 141°, respectively) suggests sp2 hybridization.
Thus we conclude that the L-arginine substrate is coordi-
nated to manganese, as suggested [12], but through its ter-
minal amino, not imino, nitrogen.
In order to explore further the implications of this struc-
ture, the crystal was dissolved, assayed for activity and
found to be inactive (<20 U/mg) within the limits of the
assay. To determine whether activity could be restored by
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Figure 4
Substrate and inhibitor binding to 
B. caldovelox arginase. (a) Recognition of the 
α-amino and α-carboxyl groups. Three
structures are superimposed: the 
L-arginine–arginase complex (in magenta) and
the L-ornithine and L-lysine inhibitor complexes
(in green and blue, respectively). Hydrogen
bonds are shown as broken lines. These
interactions are the same for each complex.
(b) Interactions of the guanidino group of the
L-arginine substrate. The substrate complex
(magenta) is superimposed on to the pH 8.5
native structure (cyan). The two manganese
ions of the native structure are shown as large
green spheres, bridged by the
water/hydroxide (small cyan sphere). The MnA
atom of the substrate complex is shown as a
large magenta sphere and the water molecule
that replaces MnB with a small magenta
sphere. The substrate displaces two water
molecules: Nη2 replaces a water ligand to
MnA and Nε displaces a second 
(non-coordinated) water molecule. The bound
substrate is shown in orange ball-and-stick
representation. (c) Interactions of the ε-amino
groups of the two inhibitors, L-lysine (blue)
and L-ornithine (green). (The figure was
prepared with MOLSCRIPT [36] and Raster
3D [37,38].)
reincorporation of the second manganese ion, the crystals
were washed in fresh mother liquor and subsequently sus-
pended in 5 µl of mother liquor containing 5 µM MnCl2.
The supernatant was assayed and found to contain no activ-
ity, indicating that the crystals had not dissolved. Ornithine
was detected in the supernatant and this must have been
generated by the hydrolysis of arginine in the crystals. We
therefore conclude that arginase in the crystals is enzymati-
cally active and that Mn2+, arginine and ornithine are able to
diffuse into and out of the crystal lattice.
As arginase loses activity when MnB is removed and then
regains enzymatic activity on the addition of manganese
ions, we conclude that, under the conditions of crystalliza-
tion, the loss of one manganese ion from the active site is
sufficient to compromise activity and that both manganese
ions are required for full activity. Scolnick et al. [19]
recently obtained structures for rat arginase in which MnA
has been removed and shown their protein to be inactive.
Taken together with our results, this shows that neither
manganese ion on its own can support optimal catalysis,
implying that a pair of manganese ions may be required to
lower the pKa of a bridging water molecule sufficiently to
generate active hydroxide. 
Inhibitor binding
Binary complexes were prepared both with the reaction
product, L-ornithine, and with L-lysine, which is the
strongest inhibitor of arginase from among the 20 com-
monly occurring amino acids, and is approximately half as
potent as L-ornithine (Ki = 550 µM, pH 9.0 at 60°C). Both
are competitive inhibitors.
Crystals of L-ornithine in complex with arginase were
grown by cocrystallization from a solution containing a
racemic mixture of D/L-ornithine and the structure was
solved as described (see Materials and methods section).
Density corresponding to an L-ornithine molecule and two
manganese ions was clearly visible at the active site.
L-Ornithine binds in an analogous position to L-arginine
with its Nε atom occupying the position of the L-arginine
Nε. The amino group is surrounded tetrahedrally by three
potential hydrogen-bond acceptors; as with L-arginine,
the Nε atom makes an interaction with Asp126 Oδ1, but
L-ornithine makes additional hydrogen bonds with the
bridging water/hydroxide and the carbonyl oxygen atom of
His139 (Figure 4c). The Nε atom is also 3.3 Å from the
ring plane of His139, in position for a possible amino–aro-
matic interaction. 
Crystals of the L-lysine–arginase complex were grown by
cocrystallization of arginase with L-lysine and the structure
solved as described (see Materials and methods section).
Electron density corresponding to an L-lysine molecule was
clearly visible. The lysine sidechain is one methyl group
longer than that of ornithine and binds in an analogous
way, in an extended conformation, with the Cε atom of
lysine in a similar position to Nε of ornithine (Figure 4c).
The Nζ of lysine is thus unable to form the same hydro-
gen bonds as ornithine, instead forming a hydrogen bond
to Oε2 of Glu271 and a water molecule. It may also form
a third hydrogen bond, to the manganese-bound hydrox-
ide, but this interaction appears less favorable geometri-
cally than that of the L-ornithine amino group. L-Lysine
thereby still utilizes its full hydrogen-bonding potential,
consistent with its ability to inhibit arginase, but it is
bound to fewer protein groups and with poorer geome-
try than is L-ornithine, consistent with L-lysine being a
weaker inhibitor.
Each binary complex was superimposed onto the structure
of the native protein. All common atoms superimpose,
that is, all atoms in the mainchain and upto the third atom
of the sidechain superimpose well. The Cε of lysine
superimposes onto the Nε of ornithine and arginine and
the Nζ of lysine superimposes onto the Cζ of arginine.
This provides strong evidence that arginine binds in a
physiological manner and allays our concern that removing
one of the manganese ions might have caused the sub-
strate to bind in a non-physiological manner due to the
absence of the second metal ion. It also demonstrates that,
at least in B. caldovelox arginase, lysine does not inhibit by
direct coordination to MnB, as previously suggested [12],
and that the ornithine binding seen in rat arginase in
complex with ornithine and borate [25] is very likely to
represent a secondary, non-physiological binding mode, as
discussed earlier.
Implications for the catalytic mechanism
Two alternative mechanisms have been proposed for argi-
nine hydrolysis by arginase. In the first mechanism (1) the
substrate is bound noncovalently, whereas in the second
mechanism (2) the substrate binds covalently to one of the
manganese atoms, MnB [12]. In both mechanisms, the
substrate is hydrogen bonded to Glu277 (Glu271 in B. cal-
dovelox arginase) although the mode of binding is differ-
ent. Arginine binds as a neutral species in mechanism 2
having lost a proton to His139, but as a charged species in
mechanism 1. Nucleophilic attack is by the bridging water
molecule (assumed to be a hydroxide ion, stabilized by
forming a hydrogen bond to Asp128) in mechanism 1, but
by a terminal water/hydroxide created by the breakage of
the aquo bridge in mechanism 2. In the latter case, break-
age of this bridge is proposed to be accompanied by a ‘car-
boxylate shift’ in which Asp232 changes from O-bridging
to O,O-bridging. In each case, collapse of the tetrahedral
intermediate is accompanied by proton transfer to the Nε
atom of arginine, which becomes the terminal amino group
of ornithine. 
The structures determined here allow us to comment on
several aspects of the proposed mechanisms. Firstly, the
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substrate appears to bind one of the manganese ions via a
terminal nitrogen, as proposed in mechanism 2; however,
our results indicate that the interaction is via the amino
not imino nitrogen, and to MnA, not MnB, as suggested
[12]. In doing so, this nitrogen atom replaces a weakly
bound water ligand, thus causing minimal disruption to
the structure. The substrate guanidine group is also hydro-
gen bonded to Glu271 (Glu277 in rat) as proposed, but in
a manner different from either mechanism. Our structure
shows that the substrate guanidine group is sandwiched
between the dimanganese site and the imidazole ring of
His139 (His141 in rat); this defines the orientation of the
guanidine plane, parallel to that of His139, and also defines
its hydrogen-bonding interactions.
The guanidine group of the substrate appears to be in an
unprotonated state in agreement with mechanism 2. This
is suggested both by its interaction with manganese and
by the geometry of its interactions (see earlier). The
proton could go to His139, which is given a proton transfer
role in both mechanisms. This residue is hydrogen
bonded to Glu271, however, and for His139 to function as
a base, accepting the proton from the incoming substrate,
it would have to be unprotonated in the resting enzyme,
even though hydrogen bonded to the negatively charged
Glu271. The clearest role for His139 is an orientational
one, positioning the guanidine group of the substrate opti-
mally for attack by the nucleophile. The substitution of
His141 with asparagine severely reduces activity (∼10% of
wild type), but does not abolish activity completely [26].
Superposition of the L-arginine complex structure onto
that of the native enzyme (Figure 4b) shows that the dis-
tance between the bridging water/hydroxide and the Cζ
atom of the substrate is ∼2.3 Å in a direction approxi-
mately normal to the guanidine plane. This geometry is
ideal for nucleophilic attack on Cζ and provides strong
evidence that the bridging water/hydroxide is the catalytic
nucleophile. Although µ-aquo or hydroxo bridges between
metal ions are relatively poor nucleophiles, our results
indicate that the binding of the bridging oxygen between
the manganese ions in our native structure is asymmetric
and one or other Mn–O bond might be weakened during
catalysis. We do not think it likely that there is any major
disruption of the dimanganese site, however, as envisaged
in mechanism 2; all of the manganese ligands are con-
strained by hydrogen bonding, and the proposed carboxy-
late shift of Asp232 (Asp226 in our structure) would
involve significant structural change.
One of the manganese ligands, Asp126, appears to be posi-
tioned to have an important role in catalysis. In the native
enzyme, a potential hydrogen bond (distance 3.0 Å) exists
between the non-coordinated carboxylate oxygen atom Oδ2
of Asp126 and the bridging water/hydroxide (Figure 3). An
analogous interaction exists in the rat arginase structure
(involving Asp128). This residue may therefore act as an
essential base, and the combined effects of bridging two
positive metal ions coupled with the proximity of this base
should favor conversion of the bridging water to hydrox-
ide. In the substrate- and  ornithine-bound complexes,
Asp126 Oδ2 forms a hydrogen bond to the Nε atom of the
arginine substrate (2.8 Å) and ornithine (2.9 Å), respec-
tively. As catalysis involves protonation of Nε, it seems
plausible that a proton is moved from the bridging water
to Nε via Asp126 Oδ2.
Several striking parallels exist between the active site of
arginase and that of another dimanganese enzyme, the
proline-specific aminopeptidase from Escherichia coli [27].
In both enzymes, the bridging water/hydroxide (assumed
to be hydroxide) is perfectly placed to be the nucle-
ophile, ∼2.3 Å from the carbon to be attacked, and in
both enzymes a carboxylate ligand to manganese has a
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Figure 5
The conformational change in the 12–20
loop. In the pH 5.6 structure (yellow), Gln15
is external and Arg18 is internal forming a
salt bridge to Glu271. In the pH 8.5 structure
(blue), Gln15 is internal and Arg18 is external.
Residue labels refer to the pH 5.6 structure.
The active site manganese ions (magenta
spheres) and bridging water/hydroxide
(green) are also shown. (The figure was
prepared with MOLSCRIPT [36] and Raster
3D [37,38].)
non-coordinated carboxylate oxygen in position to hydro-
gen bond to this species. This observation reinforces the
view that these have essential roles in catalysis.
A second arginine-binding site and its relevance to activity
The differences between the active sites in the native
enzyme and binary complexes have been described in
terms of substrate and inhibitor binding. During refine-
ment, additional density was also observed at the
monomer–monomer interfaces. The C2221 crystal form
described here, and used to derive the pH 8.5 native
structure and those of the binary complexes, was obtained
in the presence of 10 mM guanidine hydrochloride. On
the other hand, neither the pH 5.6 crystal form nor the
three other crystal forms analyzed (grown at pH 7.0 and
pH 8.5; not described here) were prepared in the presence
of guanidine hydrochloride. When we compared the
pH 8.5 and pH 5.6 holoenzyme structures, it was apparent
that a rearrangement of the loop 12–20 had taken place,
and that this could be important for catalysis. The
rearrangement transfers Arg18 from an external position at
pH 8.5 (also corresponding to the position of the analo-
gous arginine in the rat enzyme) to an internal position at
pH 5.6 (see Figure 5). Initially, we ascribed the conforma-
tional change to crystal packing, but further analysis leads
us to an alternative explanation that has important impli-
cations for activation.
The rearrangement of the 12–20 loop is not due to pH, as
the structure seen at pH 5.6 is also seen in the pH 7.0 and
pH 8.5 crystal forms prepared in the absence of guanidine
hydrochloride (MCB, PDJ, MLP and ENB, unpublished
results). Although the latter structures have more limited
resolution (3.1–4.0 Å) they have been fully refined and the
loop conformations tested by simulated annealing omit
maps. The critical factor seems to be the presence of
guanidine hydrochloride. The pH 8.5 native structure and
the inhibitor complexes all have a guanidinium ion bound
at the interface between two subunits of a trimer
(Figure 6a). This guanidinium ion is stabilized by biden-
tate hydrogen bonding to Oε1 and Oε2 of Glu256 in one
monomer and by a bifurcated hydrogen bond to
Asp199 Oδ2 of a second monomer (Figure 6b). Both
Asp199 and Glu256 are conserved in all published
arginase protein sequences with the exception of those for
Synechosystis and Arabidopsis thalania, which contain the
lowest sequence identity of all arginases. 
Surprisingly, the L-arginine–arginase complex contained
density corresponding to an L-arginine molecule at this
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Figure 6
The external arginine/guanidine-binding site
showing bound ligands in ball-and-stick
representation. (a) The binding site is located
between helix αH of one molecule of B.
caldovelox arginase (shown in magenta) and
helix αF of a second molecule (shown in
yellow) of the trimer. In the native structure,
crystallized in the presence of guanidine
hydrochloride, a guanidine ion (yellow)
occupies this site located between Asp199 of
one molecule and Glu256 of the other. In the
L-arginine-bound complex, the guanidinium
group of an arginine molecule (magenta)
precisely fills the same site. In the rat arginase
structure [11], an endogenous arginine
residue, Arg308, from the C-terminal
extension (shown in green) fills the same
position (here helices αF and αH of rat
arginase are in cyan and green, respectively).
(b) Hydrogen-bond interactions (dashed lines)
at the external binding site. The guanidine ion,
arginine ligand and Arg308 sidechain are
superimposed with the superposition defined
by the protein structures. The color scheme is
the same as for (a). (The figure was prepared
with MOLSCRIPT [36] and Raster 3D
[37,38].)
guanidine site. The guanidinium group of the arginine
ligand occupies an analogous position to the guanidinium
ion of the inhibitor complexes and makes similar interac-
tions. The temperature factors of the arginine sidechain
are lower than for its peptide end, suggesting that recog-
nition depends primarily on the guanidinium group rather
than the peptide. Comparison of the temperature factors
of the arginine ligands at the monomer interface and in
the active site of the L-arginine–arginase complex suggest
that the arginine at the monomer–monomer interface
(average B factor for all sidechain atoms 16 Å2 ) is bound
at least as tightly as the one in the active site of the
enzyme (average B factor for all sidechain atoms 23 Å2).
The interface site seems to be specific for arginine as in
the presence of either D/L-ornithine or L-lysine the site is
occupied by a guanidine ion, and is only displaced by
L-arginine.
Superimposition of the structure of rat arginase with our
model revealed that in the rat enzyme, the guanidinium
group of Arg308 (rat numbering) from a neighboring
residue of the same monomer occupies exactly the same
site, making hydrogen-bonding interactions with the con-
served aspartate and glutamate ligands. When these groups
are superimposed, the guanidino groups also superimpose
(Figure 6). Arg308 in the rat enzyme belongs to the C-ter-
minal extension that is deleted in B. caldovelox arginase. 
The binding of either L-arginine or a guanidine ion at the
monomer interface can be linked to the rearrangement of
the 12–20 loop. Binding at this external site alters the con-
formation of His252 and Tyr248, which in turns leads to a
slightly different packing arrangement between adjacent
monomers. The change in these residues causes the
monomers to rotate by ~5° about the point where the
C-terminal residue (299) packs against another monomer.
As a result of altered monomer packing within the
hexamer, the trimer–trimer interactions change, although
these still involve similar regions of the monomer. The
altered packing of these residues correlates with a confor-
mational change in residues 12–20 at the periphery of the
trimer–trimer interface.
Residues 12–20 form part of the rim of the active-site
cavity and their movement (Figure 5) has significant
impact on other active-site residues. In the pH 8.5 struc-
tures Gln15 is folded inwards, making a number of stabi-
lizing hydrogen bonds (also present in the rat enzyme),
and Arg18 is external. In the pH 5.6 structure and other
crystal forms with the guanidine site unoccupied, Gln15 is
external and Arg18 swings inwards to form a salt bridge
with Glu271 and hydrogen bond to Thr240, both at the
active site. The guanidinium group of Arg18 stacks with
the imidazole ring of His139 changing the rotamer for this
sidechain. The consequences are that the orientations of
His139 and Thr240, both involved in substrate binding,
are changed and the substrate is unlikely to be able to
bind productively.
We propose that binding of arginine to the external site
at the monomer–monomer interface of the trimer acti-
vates B. caldovelox arginase, by stimulating the movement
of the 12–20 loop and Arg18, so releasing the active-site
residues to assume their active conformations. We assume
that this mechanism only applies to those arginases that
lack an endogenous arginine to fill this external site, and
probably only those that are hexameric. Further, the
linkage of changes in oligomerization with occupation of
the remote arginine site and changes in activity suggests
a mechanism by which the activity of one component in
a hetero-oligomeric complex could regulate another, that
is, the ‘epienzymatic regulation’ shown by some micro-
bial arginases [28].
Biological implications
The amino acid L-arginine and its hydrolysis product
L-ornithine are central to many aspects of nitrogen
metabolism, including, in higher species, the urea cycle,
the biosynthesis of proline, polyamines and creatine and
the production of nitric oxide. The enzyme arginase,
which hydrolyzes L-arginine to L-ornithine and urea,
thus sits at a metabolic break-point. In humans, point
mutations in the arginase gene are associated with the
severe condition of hyperargininemia, which results in
mental retardation, spasticity and early death. Arginase
is inhibited by its product, L-ornithine, and by other
amino acids and small molecules. In Bacillus subtilis and
Saccharomyces cerevisiae, arginase exhibits epienzymatic
regulation by forming a complex with ornithine transcar-
bamylase to regulate ornithine biosynthesis. 
Crystal structures of arginase from Bacillus caldovelox,
in two different crystal forms and in complex with its
substrate L-arginine and the inhibitors L-ornithine and
L-lysine, offer new insights into arginase activity. The sub-
strate binds adjacent to a dimanganese centre and is coor-
dinated to one of the manganese ions. The guanidine
group of the  substrate fulfils its full hydrogen-bond poten-
tial and its position, between the metal-bound water/
hydroxide and the conserved His139 residue, explains
the roles of these groups in catalysis. The competitive
inhibitors L-ornithine and L-lysine are anchored by a
network of conserved hydrogen bonds at the α-amino and
α-carboxyl end, which explains the stereospecific binding
of the L-isomers of both substrate and inhibitors.
The crystal structures also show that B. caldovelox
arginase has a second arginine-binding site that might
potentially regulate activity. Occupation of this remote
site, which is located at the monomer–monomer inter-
face of the trimer substructure, leads to a slight subunit
reorientation and the rearrangement of a loop near the
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active-site, which we suggest generates a catalytically
competent active site. In common with the majority of
eukaryotic arginases, rat arginase has an extended C-ter-
minal region; this region contains an endogenous argi-
nine residue that occupies this remote site in the
structure. This observation suggests that arginases from
higher organisms might have evolved to either eliminate
regulation by substrate concentrations, by mimicking the
interactions with substrate found in the arginases of
lower organisms, or might regulate themselves by
removal of the arginine sidechain at this site. 
Materials and methods
Crystallization
B. caldovelox arginase was expressed in E. coli and purified as
described previously [29]. A number of different crystal forms were
grown, of which two are described here. In all cases, crystals were
grown by the hanging-drop method, mixing 2 µl of protein solution
(B. caldovelox arginase 27.3 mg/ml, in 10 mM MOPS, pH 7.5) with
2 µl of reservoir solution. Form I crystals were grown at room tempera-
ture using 3–6% n-butanol in 0.1 M citrate buffer, pH 5.6. Typical crys-
tals of dimensions 0.3 × 0.3 ×0.4 mm grew as trapezoidal prisms over a
period of two to three weeks. Prior to data collection, crystals were
transferred to a synthetic mother liquor of 10% n-butanol, 40% ethyl-
ene glycol in 0.1 M MES, pH 5.6, which served as a cryoprotectant.
The crystals belong to space group P212121 with cell dimensions
a = 83.6 Å, b = 145.6 Å, c = 155.4 Å. Assuming six molecules in the
asymmetric unit, VM is 2.43 Å3/Da and the solvent content is 49% [30].
Form II crystals were grown overnight at room temperature in 27–30%
monomethyl polyethylene glycol 5000, 10 mM MnCl2, 10 mM guani-
dine hydrochloride, in 0.1 M BisTrisPropane/HCl (BTP/HCl), pH 8.5.
The crystals were transferred into a cryoprotectant comprising 45%
monomethyl PEG (mmPEG) 5000, 10 mM MnCl2, 10 mM guanidine
hydrochloride, 0.05 M BTP/HCl, pH 8.5, before data collection. The
crystals belong to space group C2221, with cell dimensions a = 106.22 Å,
b = 275.58 Å, c = 138.07 Å. Assuming six molecules in the asymmetric
unit, VM = 2.67 Å3/Da and the solvent content is 54% [30].
Structure determination
All data were collected at 113K, with an R-Axis IIC image-plate detec-
tor mounted on a Rigaku RU-200 rotating-anode generator with Cu-Kα
radiation (λ = 1.5418 Å). The data were processed with the programs
DENZO [31] and SCALEPACK [31]. Full details are given in Table 1.
The structures were all solved by molecular replacement using AMoRe
[32]. The first structure solved was that of an orthorhombic crystal form
for which only medium resolution data (to 3.7 Å) could be obtained
(data not shown). This crystal form, obtained at pH 8.5 and without
guanidine hydrochloride, had three arginase monomers in the asym-
metric unit and was solved using a search model that comprised the rat
liver arginase monomer minus water molecules and manganese ions.
The trimer thus generated was used to solve the two crystal forms
reported here, which diffract to much higher resolution and both
contain six molecules in the asymmetric unit. 
The models were built using the graphics programs TOM and CHAIN
into three- or sixfold averaged maps and refined using X-PLOR [33].
Strict noncrystallographic symmetry (NCS) constraints were main-
tained during most of the refinement, being replaced with tight NCS
restraints only in the final stages of refinement. Individual atomic
B factors were refined in the latter stages of refinement and the Engh
and Huber geometrical parameters [34] were used throughout. There
is only one region where NCS is not obeyed: in the pH 5.6 structure,
residues 149–152 have a different conformation in monomers A and C
to that in monomers B, D, E and F. The structures are well defined, with
only two regions of uncertainty: in the pH 8.5 structure, the N-terminal
residue is missing and in both structures there is poor density for an
exposed surface loop (residues 55–63). The latter are included in both
models but have high B factors (70–100 Å2) and different conforma-
tions, possibly as a result of crystal-packing differences. Both models
have good stereochemistry and all residues fall in the allowed region of
the Ramachandran plot, with 90% of residues falling within the most
favorable region, as defined by PROCHECK [13]. Two cis peptides
have been found, at Gly96–Gly97 and Ser161–Pro162. The peptide
between Gly96 and Gly97 was initially modeled in the trans configura-
tion. During the final stages of refinement of the form II (pH 8.5) struc-
ture, however, distortions of the geometry, particularly the Cα−C–N
angle, and difference density around the mainchain atoms became
evident. A simulated annealing omit map, calculated with residues
95–98 removed, showed that the density could be better modeled as a
cis peptide; in subsequent refinement with 96–97 as a cis peptide
there was no longer any difference density in the maps and the geome-
try was better behaved. Evidence for a cis peptide in this position in the
pH 5.6 crystal form was less clear, because of the lower resolution, but
it was readily modeled as such. The manganese ions were judged to
be present at full occupancy in the pH 8.5 structure, because their B
factors matched those of surrounding atoms, but in the pH 5.6 form the
B factors assumed higher values; they were therefore set at the
average of the surrounding atoms and refinement of the metal occu-
pancies gave values of 60%. 
Binary complex crystallization
Crystals of inhibitor-bound complex were prepared by cocrystalliza-
tion of arginase with the inhibitors in hanging drops. The reservoir con-
tained 28% mmPEG 2000, 10 mM guanidine hydrochloride, 5 mM
MnCl2, in 50 mM BTP/HCl, pH 8.5 and either 10 mM D/L-ornithine or
10 mM L-lysine. The drops comprised 2 µl of reservoir solution and 2 µl
of protein solution. Crystals grew as rhombohedral prisms in 24–30 h.
These crystals were isomorphous with the native form II crystals, with
cell dimensions that were the same within experimental error. Prior to
data collection the crystals were transferred to a cryogenic mother
liquor comprising 42.5% mmPEG 2000, 10 mM guanidine hydrochlo-
ride, 5 mM MnCl2 and either 10 mM D/L-ornithine or 10 mM L-lysine, in
100 mM BTP/HCl, pH 8.5.
The substrate-bound complex was prepared by growing arginase crys-
tals in 28% mmPEG 2000, 10 mM guanidine hydrochloride, 10 mM
EDTA, in 50 mM BTP/HCl, pH 8.5, and soaking the crystals in 42.5%
mmPEG 2000, 10 mM guanidine hydrochloride, 10 mM l-arginine and
10 mM EDTA in 50 mM BTP/HCl, pH 8.5 for 8h. Again these crystals
were isomorphous with the native form II crystals. As the soaking
solution acts as a cryoprotectant the crystals could be mounted in a
loop directly.
Structure determination
For each of the complexes the hexamer was first optimized by rigid-
body refinement. Initial stages of refinement used a monomer with NCS
constraints, moving to the NCS-restrained hexamer only in the latter
stages of refinement, after the ligands had been placed. The geometry
of the manganese-binding sites was deduced from NCS-restrained
refinements with the restraints on manganese geometry removed. Crys-
tallographic refinement and atomic absorption spectra measurements
determined the manganese occupancies. Each of the structures
described here corresponds to residues 2–299 of the B. caldovelox
arginase sequence, with only the N-terminal methionine residue not
being visible in the electron-density maps. The refinement statistics are
shown in Table 1. None of the structures contained backbone torsional
angles in the disallowed regions of a Ramachandran plot.
Characterization of metal ion content by atomic absorption
spectroscopy
All buffer stock solutions were treated with CHELEX-100 resin (AR,
Bio-Rad). A solution of arginase (10 mg/ml) in 20 mM MOPS/NaOH,
pH 7.5 was dialyzed against two changes of 20 mM BTP/HCl, 1 mM
EDTA, pH 8.5 at 25°C for 24h followed by dialysis against two
changes of 20 mM MOPS/NaOH, pH 7.0 for 15 h. The dialyzed
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arginase solution was diluted to a concentration of 0.4 mg/ml of
protein with 20 mM MOPS/NaOH, pH 7.0 for analysis of manganese
content using a double-beam atomic absorption spectrophotometer
(Model 902, GBC).
Colorimetric assays
After data collection, the L-arginine–arginase complex crystal was
washed in mother liquor, dissolved in 20 mM MOPS/NaOH, pH 7.5
and assayed for activity using a standard protocol that is sensitive to
urea production [35]. No significant activity was found. To test whether
activity could be restored by the addition of manganese, a crystal from
the same drop was washed in mother liquor, dissolved in 1 mM MnCl2
in 20 mM MOPS/NaOH, pH 7.5 and assayed for activity in the same
way. To test whether activity could take place in the crystals, crystals of
the L-arginine–arginase complex were washed repeatedly in 47%
mmPEG 2000, 10 mM guanidine hydrochloride, 10 mM L-arginine in
50 mM BTP/HCl at pH 8.5 (solution 1). The crystals were suspended
in 50 µl of solution 1 to which 0.5 mM MnCl2 had been added L-argi-
nine was added to the resulting solution to a final concentration of
26 mM and incubated at room temperature for 15 h and the resultant
mixture centrifuged at 5000 rpm for 3 min in a microfuge. The super-
natant was assayed for ornithine and for arginase activity.
Accession numbers
The coordinates of all structures have been deposited in the Protein
Data Bank, with accession codes 1cev (native form I), 2cev (native
form II), 3cev (arginine complex), 4cev (ornithine complex) and 5cev
(lysine complex).
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